(MENAFN- EIN Presswire) Douglas Insights
Major Players operating in the dengue vaccine market include Sanofi Pasteur, Biological E. Limited, Merck & Co., Inc. Takeda Pharmaceutical Company Ltd.
DOUGLAS, ISLE OF MAN, January 23, 2023 /einpresswire.com / -- dengue vaccine market Value and CAGR
The Dengue Vaccine Market was valued at USD 375 Million in 2019 and is anticipated to reach USD 1,309 Million by 2027, expanding at a CAGR of 16% from 2019 to 2027.
Dengue fever is a viral illness that is prevalent in tropical and subtropical regions of the world and is transmitted by the Aedes mosquito. Dengue is the most rapidly spreading mosquito-borne disease in the world, with an estimated 390 million new cases each year. As there is currently no specific treatment for dengue, vaccination is the most effective method of disease control.
Dengue Vaccine Market Growth Drivers and Risks
The market for dengue vaccine is anticipated to experience significant growth in the coming years, driven by the rising prevalence of dengue fever, the rising awareness of the importance of vaccination, and the efforts of governments and health organisations to control the disease's spread. Governments and funding agencies are expected to increase their support for the development of new vaccines and the expansion of vaccination programmes in dengue-endemic nations, which is expected to benefit the market.
Despite this, the dengue vaccine market faces a number of risks and obstacles. The potential for vaccine resistance to develop, as has occurred with other vaccines, is a significant threat. In addition, the high cost of dengue vaccines may restrict their availability in developing nations where the disease is prevalent. Additionally, there is a chance of supply chain disruptions because a variety of factors, such as political unrest, natural disasters, and pandemics, can disrupt the production and distribution of vaccines.
Dengue Vaccine Market Key players
Major Players operating in the dengue vaccine market include Sanofi Pasteur, Panacea Biotec, Biological E. Limited, GlaxoSmithKline plc, Merck & Co., Inc. Takeda Pharmaceutical Company Ltd.
Check out the detailed TOC, Tables, and Figures with Charts for exclusive data, information, vital statistics, trends, and competitive landscape details.
Dengue Vaccine Market Segmentations
By End-user
.hospitals pharmacies
.Government Institutions
.Private Institutions
Reasons Why You Should Buy This Report
.The Dengue Vaccine Market report is a compilation of data from different sources and has been put together in a way that makes it easy for the reader to understand.
.It covers a wide range of topics, including Dengue Vaccine Market current trends, market size, and forecasted growth.
.The Dengue Vaccine Market report provides valuable insights that can help you make informed decisions about your business. The data is accurate and up-to-date, so you can trust the information presented.
.This Dengue Vaccine Market report is an excellent resource for business owners who are looking to gain an understanding of the market landscape and potential opportunities.
.It will help you identify growth sectors and predict future trends of Dengue Vaccine Market
Table of content
Chapter1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Dengue Vaccine Market Forces
5.1 What's Driving the Market
5.2 Porter's Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
....TOC TO BE CONTINUED.
Access complete report-
Inquire (for customization, for specific regions, etc.):
About Douglas Insights-
Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.
Office-
Bridge House, W Baldwin Rd,
Isle of Man IM4 5HA, Isle of Man
Email-
Telephone - +44 7624 248772
Web- douglasinsights.com/
nimble tech
Isabella Hawke
Douglas Insights
+ +44 7624 248772
email us here
Visit us on social media:
twitter
linkedin